Article
IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2007
Slattery Martha L, Curtin Karen, Baumgartner Richard, Sweeney Carol, Byers Tim, Giuliano Anna R, Baumgartner Kathy B, Wolff Roger R
Abstract excerpt
Interleukin-6 is a cytokine thought to be involved in inflammation, insulin, and estrogen-related pathways. We evaluate genetic variation in the IL6 gene with risk of breast cancer. We also evaluate breast cancer associations with aspirin and nonsteroidal anti-inflammatory drugs. A breast cancer case-control study (n = 1,527 non-Hispanic white cases, 1,601 non-Hispanic white controls, 798 Hispanic/Native American...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
